Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5-HT4 receptor is a serotonin receptor that stimulates cyclic adenosine monophosphate (cAMP) production in response to serotonin (5-hydroxytryptamine, 5-HT). Activation of this receptor modulates the release of various neurotransmitters and impacts several physiological processes. The primary signaling pathway involves coupling to Gs proteins, leading to activation of adenylate cyclase, increased cAMP levels, and subsequent activation of protein kinase A (PKA). It is expressed in the gastrointestinal tract, central nervous system, heart atria, and adrenal cortex. Agonists are used clinically for their prokinetic effects and it is implicated in mood regulation and potentially neurodegenerative diseases.
Agonist of the 5-HT4 receptor, leading to increased cAMP production
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-hydroxytryptamine Receptor 4 (5-HT4 Receptor).